High compliance with guideline recommendations but low completion rates of adjuvant chemotherapy in resected pancreatic cancer: a cohort study

Background: Adjuvant chemotherapy (adCx) is an integral part of multimodal treatment in resected pancreatic ductal adenocarcinoma (PDAC) and is recommended by the German S3 guideline since 2007 in all patients. We aimed to investigate the impact of this guideline at our institution. - Methods: In 15...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Weinrich, Malte (VerfasserIn) , Weiß, Christel (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2018
In: Annals of medicine and surgery
Year: 2018, Jahrgang: 32, Pages: 32-37
ISSN:2049-0801
DOI:10.1016/j.amsu.2018.06.004
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.amsu.2018.06.004
Volltext
Verfasserangaben:Malte Weinrich, Johanna Bochow, Anna-Lisa Kutsch, Guido Alsfasser, Christel Weiss, Ernst Klar, Bettina M. Rau

MARC

LEADER 00000caa a2200000 c 4500
001 1668472619
003 DE-627
005 20230427152729.0
007 cr uuu---uuuuu
008 190703s2018 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.amsu.2018.06.004  |2 doi 
035 |a (DE-627)1668472619 
035 |a (DE-599)KXP1668472619 
035 |a (OCoLC)1341232043 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Weinrich, Malte  |d 1969-  |e VerfasserIn  |0 (DE-588)121274918  |0 (DE-627)08119756X  |0 (DE-576)292621663  |4 aut 
245 1 0 |a High compliance with guideline recommendations but low completion rates of adjuvant chemotherapy in resected pancreatic cancer  |b a cohort study  |c Malte Weinrich, Johanna Bochow, Anna-Lisa Kutsch, Guido Alsfasser, Christel Weiss, Ernst Klar, Bettina M. Rau 
264 1 |c 2018 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.07.2019 
520 |a Background: Adjuvant chemotherapy (adCx) is an integral part of multimodal treatment in resected pancreatic ductal adenocarcinoma (PDAC) and is recommended by the German S3 guideline since 2007 in all patients. We aimed to investigate the impact of this guideline at our institution. - Methods: In 151 of 403 pancreatic resections performed histopathology revealed PDAC. Follow-up data were available from 143 patients (95%) representing our study group. The rate of recommended, initiated and fully completed adCx was analyzed for period 1 (09/2003-07/2007) and period 2 (08/2007-08/2014). - Results: Our study group comprised 49 patients in period 1 and 94 patients in period 2. AdCx was recommended, initiated and completed in 42/49 (86%), 34/49 (69%) and 22/49 (45%) patients in period 1 and in 93/94 (99%), 78/94 (83%) and 49/94 (52%) patients in period 2, respectively. Only the increase in recommendations for adCx was statistically significant (p=0.0024). Overall, only 50% (71/143) of patients fully completed the Cx protocol. Completed adCx resulted in a significantly longer (p=0.0225) overall survival compared to patients with incomplete or without adCx. Multiple logistic regression revealed adCx (p=0.0046) as independent factor of survival. The hazard ratio for fully completed adCx was 0.406 and for incomplete adCx 0.567. - Conclusion: Our results indicate a high acceptance of the S3-guidline recommendation for adCx in resected PDAC in a routine setting, which, however, is completed in only 50% of all patients. Fully completed adCx had the most powerful effect on improving overall survival. 
650 4 |a Adjuvant chemotherapy 
650 4 |a Cohort study 
650 4 |a Guide-line compliance 
650 4 |a Long-term survival 
650 4 |a Resected pancreatic ductal adenocarcinoma 
700 1 |a Weiß, Christel  |d 1958-  |e VerfasserIn  |0 (DE-588)123287707  |0 (DE-627)082463417  |0 (DE-576)168356104  |4 aut 
773 0 8 |i Enthalten in  |t Annals of medicine and surgery  |d London : Wolters Kluwer Health, Inc., 2012  |g 32(2018), Seite 32-37  |h Online-Ressource  |w (DE-627)774106786  |w (DE-600)2745440-X  |w (DE-576)398962782  |x 2049-0801  |7 nnas  |a High compliance with guideline recommendations but low completion rates of adjuvant chemotherapy in resected pancreatic cancer a cohort study 
773 1 8 |g volume:32  |g year:2018  |g pages:32-37  |g extent:6  |a High compliance with guideline recommendations but low completion rates of adjuvant chemotherapy in resected pancreatic cancer a cohort study 
856 4 0 |u http://dx.doi.org/10.1016/j.amsu.2018.06.004  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190703 
993 |a Article 
994 |a 2018 
998 |g 123287707  |a Weiß, Christel  |m 123287707:Weiß, Christel  |d 60000  |d 60200  |d 60250  |e 60000PW123287707  |e 60200PW123287707  |e 60250PW123287707  |k 0/60000/  |k 1/60000/60200/  |k 2/60000/60200/60250/  |p 5 
999 |a KXP-PPN1668472619  |e 349074814X 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"2018","dateIssuedKey":"2018"}],"note":["Gesehen am 03.07.2019"],"physDesc":[{"extent":"6 S."}],"title":[{"title":"High compliance with guideline recommendations but low completion rates of adjuvant chemotherapy in resected pancreatic cancer","title_sort":"High compliance with guideline recommendations but low completion rates of adjuvant chemotherapy in resected pancreatic cancer","subtitle":"a cohort study"}],"person":[{"family":"Weinrich","given":"Malte","role":"aut","display":"Weinrich, Malte"},{"role":"aut","display":"Weiß, Christel","given":"Christel","family":"Weiß"}],"relHost":[{"origin":[{"dateIssuedDisp":"2023-","publisher":"Wolters Kluwer Health, Inc. ; Elsevier","dateIssuedKey":"2023","publisherPlace":"London ; Amsterdam [u.a.]"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"774106786","pubHistory":["1.2012 -"],"id":{"zdb":["2745440-X"],"issn":["2049-0801"],"eki":["774106786"]},"part":{"extent":"6","year":"2018","volume":"32","pages":"32-37","text":"32(2018), Seite 32-37"},"title":[{"title":"Annals of medicine and surgery","title_sort":"Annals of medicine and surgery"}],"disp":"High compliance with guideline recommendations but low completion rates of adjuvant chemotherapy in resected pancreatic cancer a cohort studyAnnals of medicine and surgery","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"titleAlt":[{"title":"Annals of medicine & surgery"}]}],"name":{"displayForm":["Malte Weinrich, Johanna Bochow, Anna-Lisa Kutsch, Guido Alsfasser, Christel Weiss, Ernst Klar, Bettina M. Rau"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1668472619","id":{"eki":["1668472619"],"doi":["10.1016/j.amsu.2018.06.004"]}} 
SRT |a WEINRICHMAHIGHCOMPLI2018